CN102500006A - Medical treatment equipment for treating blood-induced diseases - Google Patents
Medical treatment equipment for treating blood-induced diseases Download PDFInfo
- Publication number
- CN102500006A CN102500006A CN2011103726806A CN201110372680A CN102500006A CN 102500006 A CN102500006 A CN 102500006A CN 2011103726806 A CN2011103726806 A CN 2011103726806A CN 201110372680 A CN201110372680 A CN 201110372680A CN 102500006 A CN102500006 A CN 102500006A
- Authority
- CN
- China
- Prior art keywords
- blood
- associated diseases
- therapeutic equipment
- treatment
- nitric oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses treatment equipment for treating blood-induced diseases. The treatment equipment comprises a first detection system for detecting the blood consistency and the temperature of blood led out of a body, a high-intensity narrow-spectrum (HINS) sterilization system used for killing bacteria and viruses in the blood detected by the first detection system, an ultrasonic decomposition system, a vacuum air exhaust system, a magnetization and energy-increasing system, a carbon monoxide input system, a temperature control cancer killing system and a second detection system. The treatment equipment has the beneficial effects that the treatment equipment for treating the blood-induced diseases can be used for confronting with tumors and controlling the spreading of cancer cells, so that the purpose of enabling cancerous patients to live with cancers for long time is achieved; and the treatment equipment achieves the purpose of lowering the blood pressure through breaking molecular aggregation, lowering the blood viscosity, reducing the blood flow resistance, increasing the blood cell deformation force and reducing microcirculation disturbance. The treatment equipment has the advantages of rapidity, high efficiency, no side effect and low cost.
Description
Technical field
The present invention relates to a kind of therapeutic equipment, relate in particular to a kind of therapeutic equipment of treating the blood associated diseases.
Background technology
The people crosses live acoustic, begins to occur refuse in a large number in the blood and gathers.With advancing age, this characteristics that appear by quantitative change to qualitative change of gathering, speed improves suddenly.Blood is taken oxygen, is got rid of intravital metabolic waste, the waste gas ability reduces, and begins to occur tired tired power, nervous breathing hard, symptom such as cough with asthma is felt suffocated, and is uncomfortable in chest.
Its essence is exactly in this period, and the stasis degree of blood in human body in liquid increases, and the hemocyte content ossifys, thereby the hemocyte deformability is descended, and causes blood transport oxygen and the ability drop of draining refuse thus, influences basal metabolism.Hypertension, coronary heart disease, pulmonary heart disease etc. begin to manifest, and old and feeble and various diseases appear in body.
Common disease is thousands of, but all with blood close getting in touch is arranged.Blood is at delivering oxygen, in the time of nutrient substance, metabolic waste, also is the passage that antibacterial, virus, cancerous tumor cell are propagated in vivo.Over thousands of year, human from initial take the drug effect plant, medical herbs develops into modern synthetic drug, gets into blood circulation through the intestines and stomach or direct injection, all is based on the treatment of the method for chemical sterilization to human body.
But the superbug that occurs has recently proposed warning to human Drug abuse treatment, the consequence of chemotherapys such as antibiotic that is widely used, thus expedited the emergence of superbacteria.And the cycle of chemicals research and development is long, lags behind advancing of disease speed, and often type of making us felt simply helpless in face of disease.
Therefore; Be badly in need of providing a kind of modality of handling based on each hemocyte and other composition of blood of facing from molecule and cellular layer in the blood in the blood class disease treatment technology; Reach and improve aerobic metabolism, raising immunity, remove the blood associated diseases.
With hypertension is example, and hypertensive essence is that the rubbish of blood accumulation increases, and various molecule group occurs and assembles, and blood viscosity is increased, and the hemocyte deformability is poor simultaneously, and the microcirculation passage stops up, and causes blood flow smooth and the heart output pressure is increased.Traditional treatment is a medicament, and for example vasodilation makes the blood vessel chap, and the passage change of blood comes blood pressure lowering greatly.But for this kind Drug therapy, long-term continual the taking medicine of needs of patients, very obvious to the side effect of pill taker's health, the probability of heart infarction and sudden death increases greatly.Therefore, this is a kind of Therapeutic Method of drinking poison to quench thirst.
Therefore, thus be badly in need of providing a kind of in the blood class disease treatment technology through breaking molecular aggregates, blood viscosity lowering in the blood, reducing blood flow resistance and increase the hemocyte deformation force, reduce microcirculation disturbance and reach blood pressure lowering destination therapeutic equipment.
Statistics shows to have only 10% people to die from infantile tumour, when can be diffused into whole body so the real problem of tumor patient is a tumor.Cancer research of today is occupied by gene and biochemical research, so we are gene therapy and chemotherapy to the main therapy of cancer now, these therapies are very big to the health side effect.At kill cancer cell simultaneously, also normal body cell is caused and kill and wound, cause the decline of body immunity.When this type patient needed most the raising body immunity, these therapies made it to descend on the contrary, and this is not brilliant therapy really.From physics's angle; The cancerous cell of these variations is with the quick mobile another kind of organism of blood; They to the sensitivity of temperature much larger than normal cell, 41.5 ℃ to normal cell under the harmless situation, the tumor cell of these variations can lose activity until being killed.In view of the above, we can open a brand-new battle line to antitumor, clutch the approach of cancerous cell diffusion, reach the purpose that the cancer patient survives with cancer for a long time.
Summary of the invention
The present invention aims to provide a kind of therapeutic equipment of treating the blood associated diseases, to solve the problem that existing BLOOD DISEASE is difficult to healing, satisfies various demands.
Goal of the invention of the present invention realizes through following technical proposals:
A kind of therapeutic equipment of treating the blood associated diseases comprises:
First detection system that blood denseness, the temperature of the outer blood of lead body detected;
Be used for killing the blood antibacterial that detected through first detection system, the HINS disinfection system of virus; Said HINS disinfection system comprises 253.7nm light quantity wavelet transmission source, and blood flow is processed by seeing through ultraviolet quartz glass, lucite or polrvinyl chloride through the pipeline of said HINS disinfection system;
The ultrasonic degradation system; Said ultrasonic degradation system is used in the space of sealing, blood being carried out ultrasonic Treatment, thereby in blood, produces cavitation, and moment produces huge impulse force; With the chemical chain that thrusts blood medium-high viscosity molecule and the gathering of group's molecule, gas is overflowed from blood;
Vacuum pumping system, said vacuum pumping system comprises vacuum pump, thereby said vacuum pump is used for making blood to produce negative pressure the harmful gas that is dissolved in blood is overflowed, to reduce harmful gas alluvial in vivo;
Magnetization energization system; Said magnetization energization system comprises a magnetic field; Thereby said magnetization energization system is used to let blood vertically form magnetization blood through said magnetic field, with the permeability that improves blood, the oxygen carrying capacity that strengthens blood, and removes the harmful oxygen-derived free radicals in the blood;
Nitric oxide input system, said nitric oxide input system be at blood after above processing, replenish oxygen and the nitric oxide lose, make blood carry oxygen and the nitric oxide that fully replenishes;
The cancer system is killed in temperature control; Said temperature control is killed the cancer system and is comprised thermostatic water tank and the logical closed blood grass tube of blood supply liquid stream; Said temperature control is killed the cancer system and is used for said closed blood grass tube is placed said thermostatic water tank, thereby makes cancer patient's blood keep whole continuous high temperature more than 120 hours, with kill cancer cell; Water temperature in the said thermostatic water tank is at 32-45 ℃, and
Second detection system, said second detection system are used for each item index that feeds back blood is detected, and after comparing with first data that detect, to confirm therapeutic effect.
Preferably, said first detection system, HINS disinfection system, ultrasonic degradation system, vacuum pumping system, magnetization energization system, nitric oxide input system, temperature control are killed between cancer system, second detection system and are connected in series through sebific duct or glass tubing.
Preferably, said HINS sterilization module is selected scalable high-frequency ultrasonic between the 20K-5000KHZ, and intensity is 0.1-0.2W/CM
2
Preferably, the temperature of said thermostatic water tank makes the blood of the said closed blood grass tube of flowing through be controlled at the 40-42.5 degree and gets into the circulation of body inner blood.
Preferably, said ultrasonic degradation system comprises a ultrasonic degradation pond, and the bottom or the side in said ultrasonic degradation pond are provided with ultrasound source.The bottom in said ultrasonic degradation pond is provided with air bleeding valve.The ultrasound source intensity in said ultrasonic degradation pond is adjustable, and intensity is 0.04-0.4W/Cm
2Further, the intensity of said ultrasound source is 0.08-0.26W/Cm
2Again further, the intensity of said ultrasound source is 0.1-0.2W/Cm
2
Preferably, said ultrasound source is the high frequency ultrasound source, and its frequency adjustable is 20KHz-5000KHz.
Preferably, the frequency of said ultrasound source is 100KHz-500KHz.The frequency of said ultrasound source is 200KHz-300KHz.
Preferably, said HINS disinfection system comprises an irradiation source, and said irradiation source is narrow spectrum ultraviolet light or lonizing radiation.
Preferably, said irradiation source is that spectral wavelength is the narrow spectrum ultraviolet light of 180 nanometers-300 nanometer.
Preferably, said irradiation source is that spectral wavelength is the narrow spectrum ultraviolet light of 253 nanometers-254 nanometer.
Preferably, the said pipeline in the said HINS disinfection system is the helical form quartz glass tube.
Preferably, said vacuum pumping system comprises input, outfan, and the switch valve of said input, outfan is a synchronous control valve, said synchronous control valve close input signal when arriving certain altitude by container inner blood liquid level output give.
Preferably, the negative pressure of said vacuum pump generation is-the 0.08-1 atmospheric pressure that the persistent period is 1 second-120 seconds.
Preferably, the negative pressure that said vacuum pump produces is the 0.1-0.5 atmospheric pressure, and the persistent period is 10 seconds-20 seconds
Preferably, the source of magnetization in said magnetic field is provided by size of current controlled coil or rubidium ferrum boron permanent magnet.
Preferably, said nitric oxide input system comprises the container that a blood is fallen by the top, is full of the pure nitric oxide by the outside input in the said container, and said nitric oxide production pressure is the 0.5-1.5 atmospheric pressure.
Preferably, the nitric oxide pressure in the said container is the 0.8-0.9 atmospheric pressure.
Preferably, said closed blood grass tube is that interior diameter is helical form glass tubing or the plastic tube of 1mm-5mm.
Preferably, said closed blood grass tube is that interior diameter is helical form glass tubing or the plastic tube of 1.5mm-2mm.
Preferably, the heat conduction media in the said thermostatic water tank is the mixture of water and glycerol.
Preferably, the heat conduction media in the said thermostatic water tank is a water.
Preferably, heat conduction media operating temperature is 41 ℃-42 ℃ in the said thermostatic water tank.
Beneficial effect of the present invention: the therapeutic equipment of treatment blood associated diseases according to the invention for to antitumor, clutch cancerous cell diffusion a kind of therapeutic equipment is provided, make the cancer patient for a long time with the purpose of cancer existence thereby reach; This therapeutic equipment has fast, and is efficient, has no side effect advantage with low cost.This therapeutic equipment is through breaking molecular aggregates, and blood viscosity lowering reduces blood flow resistance, increases the hemocyte deformation force, reduces the purpose that microcirculation disturbance has reached blood pressure lowering.
Description of drawings
Fig. 1 is the structural representation of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 2 is the structural representation in ultrasonic degradation pond of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 3 is the structural representation of HINS disinfection system of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 4 is the structural representation of vacuum pumping system of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 5 is the structural representation of magnetization energization system of the therapeutic equipment of treatment blood associated diseases according to the invention
Fig. 6 is the structural representation of nitric oxide input system of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 7 kills the structural representation of cancer system for the temperature control of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 8 is the schematic diagram of the therapeutic equipment of treatment blood associated diseases according to the invention;
Fig. 9 is first, second detection system fundamental diagram of the therapeutic equipment of treatment blood associated diseases according to the invention.
The specific embodiment
Following with reference to accompanying drawing 1-8, in conjunction with concrete embodiment the present invention is further described.
The therapeutic equipment of treatment blood associated diseases according to the invention comprises first detection system that blood denseness, temperature to the outer blood of lead body detect.Said first detection system comprises blood input port 15, blood recovery mouth 16.
The therapeutic equipment of said treatment blood associated diseases also comprises the HINS disinfection system that is used for killing the blood antibacterial that detected through first detection system, virus.Said HINS disinfection system comprises 253.7nm light quantity wavelet transmission source, and blood flow is processed by seeing through ultraviolet quartz glass, lucite or polrvinyl chloride through the pipeline of said HINS disinfection system.Preferably, said HINS disinfection system also comprises HINS light pipe 2.Preferably, said HINS disinfection system also comprises an irradiation source, and said irradiation source is narrow spectrum ultraviolet light or lonizing radiation.Preferably, said irradiation source is that spectral wavelength is the narrow spectrum ultraviolet light of 180 nanometers-300 nanometer.Preferably, said irradiation source is that spectral wavelength is the narrow spectrum ultraviolet light of 253 nanometers-254 nanometer.Preferably, the said pipeline in the said HINS disinfection system is spiral helicine quartz glass tube 1.
The therapeutic equipment of said treatment blood associated diseases also comprises the ultrasonic degradation system; Said ultrasonic degradation system is used in the space of sealing, blood being carried out ultrasonic Treatment; Thereby in blood, produce cavitation; The huge impulse force that moment produces, with the chemical chain that thrusts blood medium-high viscosity molecule and the gathering of group's molecule, gas is overflowed from blood.Preferably, said ultrasonic degradation system comprises a ultrasonic degradation pond 4, and the bottom or the side in said ultrasonic degradation pond 4 are provided with ultrasound source 5.The top in said ultrasonic degradation pond 4 is provided with steam vent 3, is provided with steam vent control valve 19 in the said steam vent 3.Said cracking pond 4 is provided with input port, cracking pond 21, cracking pond delivery outlet 20.
The therapeutic equipment of said treatment blood associated diseases also comprises vacuum pumping system; Said vacuum pumping system comprises vacuum pump; Thereby said vacuum pump is used for making blood to produce negative pressure overflows the harmful gas that is dissolved in blood, to reduce harmful gas alluvial in vivo.Preferably, said vacuum pumping system comprises input, outfan, and the switch valve of said input, outfan is a synchronous control valve 6,9, said synchronous control valve close input signal when arriving certain altitude by container inner blood liquid level output give.Said vacuum pumping system also comprises liquid level signal trigger 8, with control synchronous control valve 6,9.Preferably, said vacuum pumping system also comprises vacuum pump 7.The negative pressure that said vacuum pump 7 produces is-the 0.08-1 atmospheric pressure that the persistent period is 1 second-120 seconds.Preferably, the negative pressure that said vacuum pump 7 produces is the 0.1-0.5 atmospheric pressure, and the persistent period is 10 seconds-20 seconds.
The therapeutic equipment of said treatment blood associated diseases also comprises magnetization energization system; Said magnetization energization system comprises a magnetic field; Thereby said magnetization energization system is used to let blood vertically form magnetization blood through said magnetic field; With the permeability that improves blood, the oxygen carrying capacity that strengthens blood, and remove the harmful oxygen-derived free radicals in the blood.Preferably, the source of magnetization in said magnetic field is provided by size of current controlled coil 10 or rubidium ferrum boron permanent magnet.Said magnetization energization system also comprises the glass tubing 22 that a blood supply liquid passes through.
The therapeutic equipment of said treatment blood associated diseases also comprises the nitric oxide input system, said nitric oxide input system be at blood after above processing, replenish oxygen and the nitric oxide lose, make blood carry oxygen and the nitric oxide that fully replenishes.
Preferably, said nitric oxide input system comprises the container that a blood is fallen by the top, is full of the pure nitric oxide by the outside input in the said container, and said nitric oxide production pressure is the 0.5-1.5 atmospheric pressure.Preferably, the nitric oxide pressure in the said container is the 0.8-0.9 atmospheric pressure.Be provided with drainage screen 11 in the said container, said container also is provided with nitric oxide input port 18.
The therapeutic equipment of said treatment blood associated diseases comprises that also temperature control kills the cancer system; Said temperature control is killed the cancer system and is comprised thermostatic water tank 12 and the logical closed blood grass tube 13 of blood supply liquid stream; Said temperature control is killed the cancer system and is used for said closed blood grass tube 13 is placed said thermostatic water tank 12; Thereby make cancer patient's blood keep whole continuous high temperature more than 120 hours, with kill cancer cell, the water temperature in the said thermostatic water tank 12 is at 32-45 ℃.
Preferably, said closed blood grass tube 13 is helical form glass tubing or the plastic tube of 1mm-5mm for interior diameter.Preferably, said closed blood grass tube 13 is helical form glass tubing or the plastic tube of 1.5mm-2mm for interior diameter.Preferably, the heat conduction media in the said thermostatic water tank 12 is the mixture 14 of water and glycerol.Preferably, the heat conduction media in the said thermostatic water tank is a water.
Preferably, heat conduction media operating temperature is 41 ℃-42 ℃ in the said thermostatic water tank 12.Preferably, the temperature of said thermostatic water tank makes the blood of the said closed blood grass tube of flowing through be controlled at the 40-42.5 degree and gets into the circulation of body inner blood.
Between the top of the bottom of nitric oxide input system and thermostatic water tank, be provided with output and detect mouthfuls 23.
The therapeutic equipment of said treatment blood associated diseases also comprises second detection system, and said second detection system is used for each item index that feeds back blood is detected, and after comparing with the data of first detection system, to confirm therapeutic effect.
Preferably, said first detection system, HINS disinfection system, ultrasonic degradation system, vacuum pumping system, magnetization energization system, nitric oxide input system, temperature control are killed between cancer system, second detection system and are connected in series through sebific duct or glass tubing.
As shown in Figure 8; The puncture intubate at the human vein place; Blood is imported in the obturator outer circulation conduit as shown in the figure, and this equipment comprises first detection, HINS antibacterial, ultrasonic degradation, vacuum exhaust, magnetization energization, NO input, and second detects; Each subsystem of cancer is killed in temperature control, and blood feeds back to blood vessel after through each system.In therapeutic process, the result that first detection and second is detected compares, and when reaching unanimity, explains to have reached therapeutic effect.
First detection is to the outer blood testing each item index of lead body, comprises blood denseness, temperature etc.
The HINS disinfection system is preferred 253.7nm light quantity wavelet transmission blood, kills antibacterial, virus in the blood.
The ultrasonic degradation cell system is the important component part of this equipment, in the space of sealing, blood is carried out ultrasonic Treatment.In blood, produce cavitation, the huge impulse force that moment produces, the gathering that can thrust chemical chain and group's molecule of blood medium-high viscosity molecule, gas is overflowed from blood.Select scalable high-frequency ultrasonic between the 20K-5000KHZ, the preferred 0.1-0.2W/CM of intensity
2
Vacuum waste discharge system utilizes vacuum pump to make blood produce negative pressure, and the harmful gas that is dissolved in the blood is overflowed, and reduces harmful gas alluvial in vivo.
Magnetization energization system lets blood vertically through magnetic field, forms magnetization blood, improves the permeability of blood, and oxygen carrying capacity strengthens, and can remove the harmful oxygen-derived free radicals in the blood.
The NO input system be at blood after above processing, replenish oxygen and the nitric oxide lose, make blood carry oxygen and the nitric oxide that fully replenishes.
Temperature control is killed the cancer system closed blood grass tube is placed thermostatic water tank; Water temperature is 32--45 ℃ of accurate and adjustable in the case; Make blood be controlled at the 40-42.5 degree and get into the circulation of body inner blood, make the cancer patient keep whole continuous high temperature more than 120 hours, kill cancer cell.
Each item index to blood before second detection module is used to feed back detects, and after comparing with the data of first detection, confirms therapeutic effect, and both results' comparison is examined as three of other each module strengths selections.
As shown in Figure 9, first detection system comprises the rotation Digital Viscometer, digital thermometer, data record analysis computer, data connecting line.Second detection system comprises the rotation Digital Viscometer, the data record analysis computer (with first detection system be a computer), data connecting line, and the digital thermometer of cancer system is killed in temperature control.First detection system is done the mensuration of plasma viscosity (np1), WBV (nb1) to the outer blood of timing lead body.Measure hematid specific volume (HCT1) with wynn's method, implant procedure in computer, IR1=(nb1-np1)/np1*HCT1.Data input back computer shows the erythrocyte rigidity index IR1 that output is external.Same step can show the erythrocyte rigidity index IR2 that feeds back blood at computer.When IR1 numerical value diminishes gradually, near IR2, explain that change has taken place the stasis degree of blood, reached hypertensive therapeutic effect.Export external temperature computer and be shown as T1, the temperature setting T2 of cancer system is killed in temperature control before feeding back, and T1 raises gradually, and behind T2, the time parameter of reference settings reaches the therapeutic effect of killing tumor cell in the blood.
Certainly should recognize; Though carried out the description of front through example of the present invention, to the present invention make will to those skilled in the art conspicuous should think like this with other improvement and changing fall in the broad range of the present invention like this paper proposition.Therefore; Although the present invention with reference to preferred embodiment describe,, its meaning is not that the equipment of tool novelty is restricted therefrom; On the contrary, it is intended to comprise various improvement and equivalent modifications within the broad range that meets above-mentioned open part, claim.
Claims (10)
1. therapeutic equipment of treating the blood associated diseases comprises:
First detection system that blood denseness, the temperature of the outer blood of lead body detected;
Be used for killing the blood antibacterial that detected through first detection system, the HINS disinfection system of virus; Said HINS disinfection system comprises 253.7nm light quantity wavelet transmission source, and blood flow is processed by seeing through ultraviolet quartz glass, lucite or polrvinyl chloride through the pipeline of said HINS disinfection system;
The ultrasonic degradation system; Said ultrasonic degradation system is used in the space of sealing, blood being carried out ultrasonic Treatment, thereby in blood, produces cavitation, and moment produces huge impulse force; With the chemical chain that thrusts blood medium-high viscosity molecule and the gathering of group's molecule, gas is overflowed from blood;
Vacuum pumping system, said vacuum pumping system comprises vacuum pump, thereby said vacuum pump is used for making blood to produce negative pressure the harmful gas that is dissolved in blood is overflowed, to reduce harmful gas alluvial in vivo;
Magnetization energization system; Said magnetization energization system comprises a magnetic field; Thereby said magnetization energization system is used to let blood vertically form magnetization blood through said magnetic field, with the permeability that improves blood, the oxygen carrying capacity that strengthens blood, and removes the harmful oxygen-derived free radicals in the blood;
Nitric oxide input system, said nitric oxide input system be at blood after above processing, replenish oxygen and the nitric oxide lose, make blood carry oxygen and the nitric oxide that fully replenishes;
The cancer system is killed in temperature control; Said temperature control is killed the cancer system and is comprised thermostatic water tank and the logical closed blood grass tube of blood supply liquid stream; Said temperature control is killed the cancer system and is used for said closed blood grass tube is placed said thermostatic water tank, thereby makes cancer patient's blood keep whole continuous high temperature more than 120 hours, with kill cancer cell; Water temperature in the said thermostatic water tank is at 32-45 ℃, and
Second detection system, said second detection system are used for each item index that feeds back blood is detected, and after comparing with first data that detect, to confirm therapeutic effect.
2. the therapeutic equipment of the treatment blood associated diseases described in claim 1, it is characterized in that: said first detection system, HINS disinfection system, ultrasonic degradation system, vacuum pumping system, magnetization energization system, nitric oxide input system, temperature control are killed between cancer system, second detection system and are connected in series through sebific duct or glass tubing.
3. the therapeutic equipment of the treatment blood associated diseases described in claim 2 is characterized in that: the temperature of said thermostatic water tank makes the blood of the said closed blood grass tube of flowing through be controlled at the 40-42.5 degree and gets into the circulation of body inner blood.
4. the therapeutic equipment of the treatment blood associated diseases described in claim 2; It is characterized in that: said ultrasonic degradation system comprises a ultrasonic degradation pond; The bottom or the side in said ultrasonic degradation pond are provided with ultrasound source, and the top in said ultrasonic degradation pond is provided with air bleeding valve.
5. the therapeutic equipment of the treatment blood associated diseases described in claim 2, it is characterized in that: the ultrasound source intensity in said ultrasonic degradation pond is adjustable, and intensity is 0.04-0.4W/Cm
2
6. the therapeutic equipment of the treatment blood associated diseases described in claim 2, it is characterized in that: its frequency of said ultrasound source is 20KHz-5000KHz.
7. the therapeutic equipment of the treatment blood associated diseases described in claim 2, it is characterized in that: the pipeline in the said HINS disinfection system is the helical form quartz glass tube.
8. the therapeutic equipment of the treatment blood associated diseases described in claim 2; It is characterized in that: said vacuum pumping system comprises input, outfan; The switch valve of said input, outfan is a synchronous control valve, said synchronous control valve close input signal when arriving certain altitude by container inner blood liquid level output give.
9. the therapeutic equipment of the treatment blood associated diseases described in claim 2 is characterized in that: the negative pressure that said vacuum pump produces is-0.08-1 atmospheric pressure, and the persistent period is 1 second-120 seconds.
10. the therapeutic equipment of the treatment blood associated diseases described in claim 2; It is characterized in that: said nitric oxide input system comprises the container that a blood is fallen by the top; Be full of the nitric oxide by the outside input in the said container, said nitric oxide production pressure is the 0.5-1.5 atmospheric pressure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110372680.6A CN102500006B (en) | 2011-11-22 | 2011-11-22 | A kind of armarium for treating blood associated diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110372680.6A CN102500006B (en) | 2011-11-22 | 2011-11-22 | A kind of armarium for treating blood associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102500006A true CN102500006A (en) | 2012-06-20 |
| CN102500006B CN102500006B (en) | 2017-03-29 |
Family
ID=46212178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110372680.6A Active CN102500006B (en) | 2011-11-22 | 2011-11-22 | A kind of armarium for treating blood associated diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102500006B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105641765A (en) * | 2016-03-09 | 2016-06-08 | 江苏能瑞环保节能科技有限公司 | Blood small-molecular grouping processor for hemodialysis machine |
| US20170173247A1 (en) * | 2015-12-21 | 2017-06-22 | Hybernia Medical Llc | Methods and systems for the delivery of dissolved gases and de-gassing medical fluid lines |
| WO2019025808A1 (en) * | 2017-08-04 | 2019-02-07 | University Of Strathclyde | Improved bioreactors |
| CN109395261A (en) * | 2018-12-17 | 2019-03-01 | 周相真 | A kind of Medical Devices for treating microcirculatory disorders |
| CN113350598A (en) * | 2021-04-07 | 2021-09-07 | 刘成一 | Extracorporeal circulation treatment apparatus |
| CN113797404A (en) * | 2021-01-06 | 2021-12-17 | 郝云玲 | Device for supplementing Nitric Oxide (NO) to blood |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2041951U (en) * | 1988-09-13 | 1989-08-02 | 西安第四军医大学西京医院 | Disposable bubbling oxygenator |
| CN2063018U (en) * | 1989-12-14 | 1990-10-03 | 乌鲁木齐市友谊医院 | Tube-type machine for treating blood |
| WO1997039690A1 (en) * | 1996-04-24 | 1997-10-30 | The Regents Of The University Of California | Opto-acoustic thrombolysis |
| CN2529650Y (en) * | 2002-02-01 | 2003-01-08 | 王厚文 | Double-wave magnetic conducting quantum blood balance treatment appts. |
| CN2619582Y (en) * | 2002-10-09 | 2004-06-09 | 康立平 | Human blood viscosity detector convenient to operate |
| CN1857745A (en) * | 2005-04-30 | 2006-11-08 | 清华大学 | Miniature blood temperature changing system based on distributed control of computer |
| CN101146560A (en) * | 2005-03-24 | 2008-03-19 | Sifr2000股份有限公司 | Control of bubble formation in extracorporeal circulation |
-
2011
- 2011-11-22 CN CN201110372680.6A patent/CN102500006B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2041951U (en) * | 1988-09-13 | 1989-08-02 | 西安第四军医大学西京医院 | Disposable bubbling oxygenator |
| CN2063018U (en) * | 1989-12-14 | 1990-10-03 | 乌鲁木齐市友谊医院 | Tube-type machine for treating blood |
| WO1997039690A1 (en) * | 1996-04-24 | 1997-10-30 | The Regents Of The University Of California | Opto-acoustic thrombolysis |
| CN2529650Y (en) * | 2002-02-01 | 2003-01-08 | 王厚文 | Double-wave magnetic conducting quantum blood balance treatment appts. |
| CN2619582Y (en) * | 2002-10-09 | 2004-06-09 | 康立平 | Human blood viscosity detector convenient to operate |
| CN101146560A (en) * | 2005-03-24 | 2008-03-19 | Sifr2000股份有限公司 | Control of bubble formation in extracorporeal circulation |
| CN1857745A (en) * | 2005-04-30 | 2006-11-08 | 清华大学 | Miniature blood temperature changing system based on distributed control of computer |
Non-Patent Citations (2)
| Title |
|---|
| 耿淑琴等: "库血加热对红细胞完整性的影响", 《中华护理杂志》 * |
| 耿淑琴等: "库血加热对血液成分及携氧功能的影响", 《全国手术室护理学术交流暨专题讲座会议论文汇编》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170173247A1 (en) * | 2015-12-21 | 2017-06-22 | Hybernia Medical Llc | Methods and systems for the delivery of dissolved gases and de-gassing medical fluid lines |
| WO2017112736A3 (en) * | 2015-12-21 | 2017-08-10 | Hybernia Medical Llc | Methods and systems for the delivery of dissolved gases and de-gassing medical fluid lines |
| US10773009B2 (en) * | 2015-12-21 | 2020-09-15 | Transluminal Systems, Llc | Methods and systems for the delivery of dissolved gases and de-gassing medical fluid lines |
| AU2016377582B2 (en) * | 2015-12-21 | 2021-10-28 | Jae H. Choi | Methods and systems for the delivery of dissolved gases and de-gassing medical fluid lines |
| CN105641765A (en) * | 2016-03-09 | 2016-06-08 | 江苏能瑞环保节能科技有限公司 | Blood small-molecular grouping processor for hemodialysis machine |
| CN105641765B (en) * | 2016-03-09 | 2017-10-27 | 江苏能瑞环保节能科技有限公司 | Blood small molecule dough processor for hemo system |
| WO2019025808A1 (en) * | 2017-08-04 | 2019-02-07 | University Of Strathclyde | Improved bioreactors |
| CN109395261A (en) * | 2018-12-17 | 2019-03-01 | 周相真 | A kind of Medical Devices for treating microcirculatory disorders |
| CN113797404A (en) * | 2021-01-06 | 2021-12-17 | 郝云玲 | Device for supplementing Nitric Oxide (NO) to blood |
| CN113350598A (en) * | 2021-04-07 | 2021-09-07 | 刘成一 | Extracorporeal circulation treatment apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102500006B (en) | 2017-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102500006A (en) | Medical treatment equipment for treating blood-induced diseases | |
| CN110496140A (en) | Bacteroides fragilis or Ackermam slime bacteria are preparing the application in the drug for preventing or treating tumour | |
| Chen et al. | Clinical distribution and molecular basis of traditional Chinese medicine ZHENG in cancer | |
| CN104829738B (en) | Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes | |
| CN103156888A (en) | Application of bacteroides fragilis in preparation of composition for treating inflammatory bowel diseases | |
| CN109793761B (en) | Composition for enhancing T cell immune function and preparation method thereof | |
| CN104593326A (en) | Method for preparing enhanced DC-CIK cell induced by traditional Chinese medicines and application of enhanced DC-CIK cells induced by traditional Chinese medicines | |
| CN106955384A (en) | A kind of circulating tumor cell capturing device | |
| CN105316287A (en) | Method for long-term storage and resuscitation culture of adult peripheral blood mononuclear cell | |
| CN105586313A (en) | Culturing method for NKT cells | |
| Leung et al. | Far infrared ray irradiation induces intracellular generation of nitric oxide in breast cancer cells | |
| CN105505871B (en) | A kind of effective amplification CIK and improve the method that its specificity kills tumor ability | |
| CN109479814A (en) | The screening model of anti-lung cancer tumour medicine | |
| Zhao et al. | Negative pressure drainage‐assisted irrigation for maxillofacial space infection | |
| CN102212505B (en) | Immune killer cell, preparation method thereof, medicinal composition containing immune killer cell and set | |
| CN1895244A (en) | Medicinal composition for preventing and treating cancer diseases | |
| CN106943430A (en) | Application of the cis-platinum in the high-level grain system derived from bone marrow immunosuppressant cell carcinoma of urinary bladder for the treatment of | |
| CHEN et al. | A Review of Qigong Therapy for Cancer Treatment (< Main Topics> Human PSI Forum" Human Potential Science" International Forum: Physical and Physiological Approach Joint with" Mystery of Mind and Body" International Forum and The Fourteenth Symposium on Life Information Science (International Version) 22-27 August 2002, OVTA, Makuhari, Chiba (near Tokyo), Japan) | |
| CN203724206U (en) | Cold and hot knife with drug conveying function and system | |
| CN113892463B (en) | Peritoneal irrigation fluid tumor model for screening peritoneal and pelvic malignant tumor drugs, construction method and application | |
| CN108753719B (en) | A method of the LAK LAK of derived from cord blood is improved to tumor-killing power | |
| CN105820973A (en) | Serratia marcescens vaccine and preparation method and application thereof | |
| CN106978340B (en) | A kind of Bifidobacterium culture apparatus special | |
| CN109394784A (en) | The screening model of anti-head-neck carcinoma tumour medicine | |
| CN110464736A (en) | A kind of application of composition, hydrogen physiological saline for treating bladder cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |